Rocket Pharmaceuticals Inc banner

Rocket Pharmaceuticals Inc
NASDAQ:RCKT

Watchlist Manager
Rocket Pharmaceuticals Inc Logo
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Watchlist
Price: 4.63 USD -4.93%
Market Cap: $502.7m

Wall Street
Price Targets

RCKT Price Targets Summary
Rocket Pharmaceuticals Inc

Wall Street analysts forecast RCKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCKT is 7.86 USD with a low forecast of 2.02 USD and a high forecast of 16.8 USD.

Lowest
Price Target
2.02 USD
56% Downside
Average
Price Target
7.86 USD
70% Upside
Highest
Price Target
16.8 USD
263% Upside
Rocket Pharmaceuticals Inc Competitors:
Price Targets
CFFN
Capitol Federal Financial Inc
13% Upside
DXPE
DXP Enterprises Inc
-7% Downside
VIAV
Viavi Solutions Inc
-18% Downside
ESQ
Esquire Financial Holdings Inc
16% Upside
ACAD
ACADIA Pharmaceuticals Inc
58% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCKT's stock price target?
Price Target
7.86 USD

According to Wall Street analysts, the average 1-year price target for RCKT is 7.86 USD with a low forecast of 2.02 USD and a high forecast of 16.8 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett